Overview

Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome

Status:
Completed

Trial end date:
2008-06-25

Target enrollment:

Participant gender:

Summary

This is a double-blind, placebo-controlled, randomised crossover study to investigate the efficacy and safety of GW876008

Phase:

Phase 2

Details

Lead Sponsor:

GlaxoSmithKline